Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 159(4): 482-5, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26395624

RESUMEN

We studied in vivo antitumor effect of epimastigote form detritus of Trypanosoma cruzi, Mexican Albarrada strain, on L5178Y malignant tumor in BALB/c mice. The antitumor effect of ultrasonic detritus of the parasite was confirmed by shrinkage of the tumor and changed size of its symplastic necroses.


Asunto(s)
Antineoplásicos/farmacología , Linfoma/tratamiento farmacológico , Trypanosoma cruzi/química , Animales , Antineoplásicos/aislamiento & purificación , Línea Celular Tumoral , Ensayos de Selección de Medicamentos Antitumorales , Linfoma/patología , Masculino , Ratones Endogámicos BALB C , Trasplante de Neoplasias , Sonicación , Carga Tumoral/efectos de los fármacos
2.
Bull Exp Biol Med ; 156(1): 70-2, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24319733

RESUMEN

Comparative histopathological study and analysis of parasite load in different muscle groups were carried out in BALB/c mice during the acute phase of Chagas disease. Activities of C104 clone of T. cruzi strain TPAP/MX/2002/Albarrada and the parental strain were compared. Panoramic 2D-microscopy imaging of sample surface was used and quantitative analysis of parasitism and pathologic damage was performed. The infection rates in various muscle groups were as follows: myocardium=abdominal muscles=lumbar muscles=femoral muscles<--diaphragm for the clone and myocardium¬abdominal muscles=lumbar muscles=femoral muscles-->diaphragm for the parental strain.


Asunto(s)
Enfermedad de Chagas/parasitología , Trypanosoma cruzi/patogenicidad , Músculos Abdominales/parasitología , Animales , Diafragma/parasitología , Corazón/parasitología , Ratones , Ratones Endogámicos BALB C , Miositis/parasitología , Especificidad de Órganos , Carga de Parásitos , Trypanosoma cruzi/genética
3.
Bull Exp Biol Med ; 154(6): 762-4, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23658918

RESUMEN

Experiments with passive transfer of immunocompetent cell and serum demonstrated suppression of tumor growth after transfer of splenocytes from animals immunized with Trypanosoma cruzi. The nonspecific constituent of antitumor effect of immunocompetent cells was detected. The previously reported oncoprotective effect of mucins 2 and 3 was not confirmed.


Asunto(s)
Anticuerpos Antiprotozoarios/inmunología , Carcinoma de Ehrlich/terapia , Trasplante de Células , Bazo/citología , Trypanosoma cruzi/inmunología , Animales , Carcinoma de Ehrlich/inmunología , Carcinoma de Ehrlich/patología , Femenino , Inmunización , Ratones , Ratones Endogámicos BALB C , Mucinas/inmunología , Trasplante de Neoplasias , Proteínas Protozoarias/inmunología , Bazo/inmunología , Carga Tumoral
4.
Bull Exp Biol Med ; 149(6): 731-3, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21165432

RESUMEN

Human defensin-α(1)is a biologically active peptide exhibiting a dose-dependent trypanocidal effect in vitro against trypomastigotes and amastigotes of Trypanosoma cruzi line Tulahuen. This effect is determined by fragmentation of parasite DNA reducing the capacity of passaged T. cruzi to invade HeLa cells.


Asunto(s)
Defensinas/fisiología , Trypanosoma cruzi/fisiología , Secuencia de Aminoácidos , Animales , Defensinas/química , Humanos , Técnicas In Vitro , Datos de Secuencia Molecular
5.
Bull Exp Biol Med ; 145(3): 352-4, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19039942

RESUMEN

The experiments with passive transfer of splenocytes obtained from animals immunized with Trypanosoma cruzi lysate revealed the role of cell-mediated component of the immunity in the antitumor effect of T. cruzi. The common features of T. cruzi antigens and tumor-specific antigens of Ehrlich's adenocarcinoma were demonstrated. These antigens were shown to have common epitopes with mammalian mucins. The oncoprotective effect was achieved by immunization with type II and III mucins and was reproduced after passive transfer of splenocytes from immunized animals.


Asunto(s)
Anticuerpos Antiprotozoarios/inmunología , Antineoplásicos/farmacología , Carcinoma de Ehrlich/prevención & control , Trypanosoma cruzi/inmunología , Animales , Ratones , Ratones Endogámicos BALB C , Mucina 2/inmunología , Mucina 3/inmunología , Trasplante de Neoplasias
6.
Med Parazitol (Mosk) ; (1): 11-5, 2008.
Artículo en Ruso | MEDLINE | ID: mdl-18368713

RESUMEN

Trypanosoma cruzi antibodies that are important in the anticancer effect of this species of Trypanosoma were first detected in 14% of the 374 examined intact mice. These background antibodies were polyclonal, i.e. they reacted with one or other of 9 genetically different T. cruzi clones and detected antigenic determinants in different structures of a Trypanosoma cell. Their spread in the population varied with animal batches; the titers were not greater than 1:40 and the level remained steady during a one-month observation. The growth of Ehrlich's adenomacarcinoma inoculated to these mice was inhibited by 1.5-2.5 times and, in some cases, terminated in total regression. The paper discusses the capacities of such antibodies in man and their inductor-commonness of the antigens of the normal intestinal microflora and the cells of the vertebrate with T. cruzi.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Antineoplásicos/sangre , Carcinoma de Ehrlich/inmunología , Trypanosoma cruzi/inmunología , Animales , Anticuerpos Antiprotozoarios/inmunología , Especificidad de Anticuerpos , Antígenos de Protozoos/inmunología , Antineoplásicos/inmunología , Carcinoma de Ehrlich/diagnóstico , Progresión de la Enfermedad , Ratones , Factores de Tiempo
7.
Bull Exp Biol Med ; 142(4): 470-3, 2006 Oct.
Artículo en Inglés, Ruso | MEDLINE | ID: mdl-17415440

RESUMEN

Lyzed epimastigotes of Trypanosoma cruzi clones P209-1, Gamba1, Sp104-1, MASu, Y7/1, MN12, Cl-Brener, 86/2036, Y7/2-1 inhibit the growth of Ehrlich adenocarcinoma in mice. the tumor decreased 1.5-3 times after 12 daily injections of lysates from 15 million epimastigotes. The protective effect progressed after the injections were discontinued and depended on the dose and lysate producer clone. Trypanosoma lysates in the studied doses were nontoxic.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Antineoplásicos/aislamiento & purificación , Antineoplásicos/uso terapéutico , Carcinoma de Ehrlich/tratamiento farmacológico , Extractos Celulares/uso terapéutico , Trypanosoma cruzi/genética , Adenocarcinoma/patología , Animales , Carcinoma de Ehrlich/patología , Ratones
8.
Med Parazitol (Mosk) ; (4): 9-12, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-17290901

RESUMEN

The evidence has been produced that immunological mechanisms are involved in the known anticancer phenomenon of T. cruzi. Non-inbred albino mice were immunized with avirulent cultures of three strains and seven clones and then transplanted a tumor--sarcoma-180 or Ehrlich's adenocarcinoma. The used cultures induced the generation of T. cruzi antibodies whose level peaked by postimmunization days 50-60: the titers being 1:40-1:80 and the spread among the mice being 60%. Concurrently, immunization against T. cruzi provided a certain oncoprotective effect. In the immunized mice, the sizes of sarcoma-180 and adenocarcinoma were 1.5-2.0 and 2.0-2.5 times, respectively, less than those in the non-immunized ones. The antitumor protection was directly related to the murine blood T. cruzi antibody level during which implantation of a tumor occurred. At the peak of an immune response, the effect was 2 times higher than that in the early postimmunization periods. T. cruzi strains that were more immunogenic than clones ensured a more significant oncoprotection. The latter was more considerable in mice having antibody titers of 1:40-1:80 than in those with antibody titers of 1:10-1:20 and particularly in the animals showing no humoral response to the administration of the parasites at all.


Asunto(s)
Adenocarcinoma/prevención & control , Enfermedad de Chagas/inmunología , Inmunización , Vacunas Antiprotozoos/administración & dosificación , Sarcoma Experimental/prevención & control , Neoplasias Cutáneas/prevención & control , Trypanosoma cruzi/inmunología , Animales , Anticuerpos Antiprotozoarios/sangre , Inyecciones Intramusculares , Inyecciones Intraperitoneales , Inyecciones Subcutáneas , Ratones , Especificidad de la Especie , Factores de Tiempo , Vacunas Atenuadas/administración & dosificación
9.
Bull Exp Biol Med ; 135(1): 89-92, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12717523

RESUMEN

The direct inhibitory effect of Trypanosoma cruzi epimastigote lysates on in vitro cultured human breast cancer MCF-7 cells differs in various genetic groups and cloned subgroups of Trypanosoma.


Asunto(s)
Heterogeneidad Genética , Trypanosoma cruzi/genética , Animales , Muerte Celular , Extractos Celulares , Genotipo , Humanos , Trypanosoma cruzi/metabolismo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA